NCT02271542View on ClinicalTrials.gov

Identification of Polymorphisms Involved in the Metabolism of Propofol

PHASE4CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

UGT1A1*28 Polymorphism

Interventions

DRUG

propofol

Propofol, 1-2 mg / kg after the installation is 100 to 200 mg / kg / min infusion for 30-60 minutes after application will be made and EDTA tubes with 2 ml blood sample will be taken. Determined from blood samples obtained by studying the polymorphism genotypes of patients will be exposed.

Trial Locations (1)

38039

Erciyes University, Kayseri

All Listed Sponsors

lead

TC Erciyes University

OTHER

NCT02271542 - Identification of Polymorphisms Involved in the Metabolism of Propofol | Biotech Hunter | Biotech Hunter